Subjects: PROTO-ONCOGENES, ENDOCRINOPATIAS, NEOPLASIAS, FEOCROMOCITONIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOLEDO, S. P. A. et al. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2. Clinics, v. 61, n. 1, p. 59-70, 2006Tradução . . Disponível em: https://doi.org/10.1590/s1807-59322006000100011. Acesso em: 03 jun. 2024.APA
Toledo, S. P. A., Santos, M. A. C. G. dos, Toledo, R. de A., & Lourenço Junior, D. M. (2006). Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2. Clinics, 61( 1), 59-70. doi:10.1590/s1807-59322006000100011NLM
Toledo SPA, Santos MACG dos, Toledo R de A, Lourenço Junior DM. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2 [Internet]. Clinics. 2006 ; 61( 1): 59-70.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1590/s1807-59322006000100011Vancouver
Toledo SPA, Santos MACG dos, Toledo R de A, Lourenço Junior DM. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2 [Internet]. Clinics. 2006 ; 61( 1): 59-70.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1590/s1807-59322006000100011
